43. (Bevacizumab-Related Exclusion) History of abdominal fistula or gastrointestinal perforation within 6 months prior to the first study treatment Serious, non-healing wound, active ulcer, or untreated bone fracture (Adjuvant trials: bone fractures must be healed)